BioSpace News Archive

Business

MannKind Corporation Reports 2017 Third Quarter Financial Results

Afrezza net revenue grew 28% and 246% vs. 2Q 2017 and 3Q 2016, respectively.

November 8, 2017
·
10 min read
Business

Pernix Therapeutics Reports Third Quarter 2017 Financial Results

Third quarter 2017 net revenues were $40.5 million, an 18% increase sequentially from $34.3 million recorded in the second quarter of 2017.

November 8, 2017
·
18 min read
Business

Tocagen Reports Third Quarter 2017 Financial and Business Results

Net loss was $10.0 million, or $0.50 per common share (basic and diluted), for the quarter ended September 30, 2017.

November 8, 2017
·
11 min read
Business

Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress

Total revenue was $83.8 million in the third quarter of 2017, compared with $82.3 million in the third quarter of 2016.

November 8, 2017
·
24 min read
Business

Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

As of September 30, 2017, Aerie had cash, cash equivalents and investments of $282.2 million.

November 8, 2017
·
14 min read
Business

Nortech Systems Reports Third Quarter Results

Nortech Systems today reported net sales of $28.3 million for the third quarter ended September 30, compared with net sales of $29.7 million for the third quarter of 2016.

November 8, 2017
·
5 min read
Business

ViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017

ViewRay will hold a conference call on Monday, November 13, 2017 at 8:30 a.m. ET / 5:30 a.m. PT to discuss the results.

November 8, 2017
·
1 min read
FDA

DT MedTech Wins FDA Nod for Hintermann Series H2 Total Ankle Replacement System

The Hintermann Series H2 is a semi-constrained, total ankle replacement prosthesis developed by a world-renowned foot and ankle surgeon based in Switzerland.

November 8, 2017
·
3 min read
Business

Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly

Appointed in August 2016, Richard also served on the Board’s Audit and Compensation Committees.

November 8, 2017
·
6 min read
Business

Neos Therapeutics Reports Third Quarter 2017 Financial Results

Total product revenues were $6.7 million for the three months ended September 30, 2017, compared to $1.6 million for the same period in 2016.

November 8, 2017
·
11 min read